NCT04581824
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04581824
Title Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ROU | POL | ITA | FRA | ESP | DEU | BRA | ARG

Facility Status City State Zip Country Details
GSK Investigational Site Denver North Carolina 80128 United States Details
GSK Investigational Site Cincinnati Ohio 45242 United States Details
GSK Investigational Site Fairfax Virginia 22031 United States Details
GSK Investigational Site Buenos Aires C1426ABP Argentina Details
GSK Investigational Site Ciudad Autonoma de Buenos Aire C1012AAR Argentina Details
GSK Investigational Site Córdoba X5004FHP Argentina Details
GSK Investigational Site Florida 1602 Argentina Details
GSK Investigational Site La Plata 1900 Argentina Details
GSK Investigational Site La Rioja F5300COE Argentina Details
GSK Investigational Site Pergamino B2700CPM Argentina Details
GSK Investigational Site Rosario S2000KZE Argentina Details
GSK Investigational Site San Juan J5402DIL Argentina Details
GSK Investigational Site Viedma R8500ACE Argentina Details
GSK Investigational Site Barretos 14784-400 Brazil Details
GSK Investigational Site Fortaleza 60336-232 Brazil Details
GSK Investigational Site Natal 59075-740 Brazil Details
GSK Investigational Site Rio de Janeiro 20230 -130 Brazil Details
GSK Investigational Site São Paulo 04014-002 Brazil Details
GSK Investigational Site Vitória 29043-260 Brazil Details
GSK Investigational Site Santiago 7500653 Chile Details
GSK Investigational Site Santiago 8320000 Chile Details
GSK Investigational Site Caen 14033 France Details
GSK Investigational Site Le Mans 72000 France Details
GSK Investigational Site Limoges 87042 France Details
GSK Investigational Site Pessac 33604 France Details
GSK Investigational Site Saint-Herblain 44805 France Details
GSK Investigational Site Valenciennes 59300 France Details
GSK Investigational Site Berlin 12200 Germany Details
GSK Investigational Site Cologne 51109 Germany Details
GSK Investigational Site Frankfurt 60488 Germany Details
GSK Investigational Site Immenhausen 34376 Germany Details
GSK Investigational Site Oldenburg 26121 Germany Details
GSK Investigational Site Aviano PN 33081 Italy Details
GSK Investigational Site Brescia 25123 Italy Details
GSK Investigational Site Milan 20133 Italy Details
GSK Investigational Site Milan 20141 Italy Details
GSK Investigational Site Napoli 80131 Italy Details
GSK Investigational Site Roma 00152 Italy Details
GSK Investigational Site Bydgoszcz 85-796 Poland Details
GSK Investigational Site Lodz 90-338 Poland Details
GSK Investigational Site Lublin 20-954 Poland Details
GSK Investigational Site Olsztyn 10-357 Poland Details
GSK Investigational Site Poznan 60-693 Poland Details
GSK Investigational Site Bucharest 030442 Romania Details
GSK Investigational Site Craiova 200347 Romania Details
GSK Investigational Site Floreşti 407280 Romania Details
GSK Investigational Site Cheongju Chungcheongbuk-do 28644 South Korea Details
GSK Investigational Site Pusan 48108 South Korea Details
GSK Investigational Site Seoul 05505 South Korea Details
GSK Investigational Site Seoul 06351 South Korea Details
GSK Investigational Site Seoul 120-752 South Korea Details
GSK Investigational Site Barcelona 08003 Spain Details
GSK Investigational Site Jaén 23007 Spain Details
GSK Investigational Site Lugo 27003 Spain Details
GSK Investigational Site Málaga 29010 Spain Details
GSK Investigational Site Seville 41014 Spain Details
GSK Investigational Site Changhua 500 Taiwan Details
GSK Investigational Site Taipei 11490 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field